|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yakovleva ME, Welinder C, Sugiharaa Y,
Pawlowskid K, Rezelib M, Wieslandera E, Malme J and Marko-Varga G:
Workflow for large-scale analysis of melanoma tissue samples. EuPA
Open Proteomics. 8:78–84. 2015. View Article : Google Scholar
|
|
3
|
Essner R: Surgical treatment of malignant
melanoma. Surg Clin North Am. 83:109–156. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oliner J, Min H, Leal J, Yu D, Rao S, You
E, Tang X, Kim H, Meyer S, Han SJ, et al: Suppression of
angiogenesis and tumor growth by selective inhibition of
angiopoietin-2. Cancer Cell. 6:507–516. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Helfrich I, Edler L, Sucker A, Thomas M,
Christian S, Schadendorf D and Augustin HG: Angiopoietin-2 levels
are associated with disease progression in metastatic malignant
melanoma. Clin Cancer Res. 15:1384–1392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schlaak M, Kreuzberg N, Mauch C and
Kurschat P: Personalized therapy concepts for malignant melanoma.
Internist (Berl). 54:188–193. 2013.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boguslawska J and Małecki M: siRNA
preparations in gene therapy of melanoma. Med Wieku Rozwoj.
17:196–201. 2013.PubMed/NCBI
|
|
8
|
Dolinsek T, Markelc B, Sersa G, Coer A,
Stimac M, Lavrencak J, Brozic A, Kranjc S and Cemazar M: Multiple
delivery of siRNA against endoglin into murine mammary
adenocarcinoma prevents angiogenesis and delays tumor growth. PLoS
One. 8:e587232013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu ZL, Wang B, Guo GX, Shan XY, Wang MS,
Zhuang FL, Cai CS, Zhang MF and Zhang YD: Construction of
recombinant lentiviral vector of siRNA for Ang2 and the effect of
the expression of Ang2 gene in malignant melanoma cells. J Med Mol
Biol. 8:494–500. 2011.
|
|
10
|
Wang B, Lin JH, Zhang WQ, Zhang MF, Liu
ZL, Shan XY, Wang MS and Zhuang FL: Ang2-siRNA lentivirus
interfernce on melanoma xenograft in nude mice. J Med Mol Biol.
9:79–83. 2012.
|
|
11
|
Wang B, Liu Z, Zhang M, San X, Zhang Y,
Zhang W and Wang M: Interfering growth of malignant melanoma with
Ang2-siRNA. Mol Biol Rep. 40:1463–1471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kenjo E, Asai T, Yonenaga N, Ando H, Ishii
T, Hatanaka K, Shimizu K, Urita Y, Dewa T, Nango M, et al: Systemic
delivery of small interfering RNA by use of targeted polycation
liposomes for cancer therapy. Biol Pharm Bull. 36:287–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Todorovic V, Sersa G and Cemazar M: Gene
electrotransfer of siRNAs against CD146 inhibits migration and
invasion of human malignant melanoma cells SK-MEL28. Cancer Gene
Ther. 20:208–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stein S, Scholz S, Schwäble J, Sadat MA,
Modlich U, Schultze-Strasser S, Diaz M, Chen-Wichmann L,
Müller-Kuller U, Brendel C, et al: From bench to bedside:
Preclinical evaluation of a self-inactivating gammaretroviral
vector for the gene therapy of X-linked chronic granulomatous
disease. Hum Gene Ther Clin Dev. 24:86–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bonamassa B and Liu D: Nonviral gene
transfer as a tool for studying transcription regulation of
xenobiotic metabolizing enzymes. Adv Drug Deliv Rev. 62:1250–1256.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Rorke S, Keeney M and Pandit A:
Non-viral polyplexes: Scaffold mediated delivery for gene therapy.
Prog Polym Sci. 35:441–458. 2010. View Article : Google Scholar
|
|
17
|
Sionkowska A, Wisniewski M, Skopinska J,
Kennedy CJ and Wess TJ: Molecular interactions incollagen and
chitosan blends. Biomaterials. 25:795–801. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pang SW, Park HY, Jang YS, Kim WS and Kim
JH: Effects of charge density and particle size of poly
(styrene/(dimethylamino)ethyl methacrylate) nanoparticle for gene
delivery in 293 cells. Colloids Surf B Biointerfaces. 26:213–222.
2002. View Article : Google Scholar
|
|
19
|
Mansouri S, Lavigne P, Corsi K, Benderdour
M, Beaumont E and Fernandes JC: Chitosan-DNA nanopartieles as
non-viral vectors in gene therapy: Strategies to improve
transfection efficacy. Eur J Pharm Biopharm. 57:1–8. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sato T, Ishii T and Okahata Y: In vitro
gene delivery mediated by chitosan. Effect of pH, serum, and
molecular mass of chitosan on the transfection efficiency.
Biomaterials. 22:2075–2080. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kiang T, Wen J, Lim HW and Leong KW: The
effect of the degree of chitosan deacetylation on the efficiency of
gene transfection. Biomaterials. 25:5293–5301. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin
KY, Wang Y, August JT and Leong KW: Chitosan-DNA nanoparticles as
gene carriers: Synthesis, characterization and transfection
efficiency. J Control Release. 70:399–421. 2001. View Article : Google Scholar : PubMed/NCBI
|
